Scientists at Sirtris Pharmaceuticals have conducted research on fattened rodents to test the utility of a chemical that mimics resversatrol. Resversatrol is a key compound in red wine. After examining 500 thousand compounds, the scientists located a compound that is a thousand times more potent. Human studies will begin in 2008. The results could lead to treatment for Diabetes and other age related cell degeneration diseases.

Scientists at the Sirtris Pharmaceuticals in Cambridge, Massachusetts under the direction of Christoph Wesphal have located chemicals that mimic resveratrol, the key ingredient in red wine. The Sirtris scientists published their findings in the current update of Nature-Signaling Gateway on November 30, 2007.